Bildkälla: Stockfoto

Lagercrantz: Margin holding up well - ABG

Adj. EBITA 1% below ABGSCe, -3% vs cons.
Managing the component shortage well
29x NTM EBITA with solid growth prospects

Q2’21/22 was roughly in line with expectations on headline items. Sales were SEK 1,201m (-1%% vs. ABGSCe at 1,209m and -3%% vs. Infront consensus at 1,236m), up 31% y-o-y, of which 13% is organic growth (14% ABGSCe). All segments were strong and contributed to the volume growth. Additionally, Lagercrantz delivered another quarter of strong EBITA margins at 16.0% (ABGSCe 16.0%, cons. 16.0%), corresponding to adj. EBITA of SEK 192m (-1% vs. ABGSCe at 194m, -3% vs. cons. at 198m). The biggest deviation was on Net Income at 116m (-9% vs. ABGSCe at 127m, -6% vs. cons. At 124m), explained by higher-than-expected net financials. All in all, we consider the report to be solid and note that R12m EBT is SEK 641m. As such, the target of SEK 1bn in EBT to ‘25e seems well within reach.

The share is trading at 29x NTM EV/EBITA, 4% below core peers (Addtech, Indutrade, Lifco and Sdiptech), but 94% above its five-year average. Lagercrantz’ ‘21e ND/EBITDA of 1.7x and focus on profitable growth (organic and acquired) bodes well for the company to be able to grow faster than its five-year average of 10% p.a.
Börsvärldens nyhetsbrev
ANNONSER